Portfolio (Quarterly)
Guide ↗
Soleus Capital Management, L.P.
· CIK 0001802630| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | INDV | INDIVIOR PHARMACEUTICALS INC | Healthcare | 1,274,000.0 | $38.8M | 1.57% | NEW | — | $30.48 | +23.1% |
| 2 | PGNY | PROGYNY INC | Healthcare | 2,067,000.0 | $35.1M | 1.42% | NEW | — | $16.98 | +46.5% |
| 3 | MRK | MERCK & CO INC | Healthcare | 203,000.0 | $24.4M | 0.99% | NEW | — | $120.29 | +1.8% |
| 4 | ICLR | ICON PLC | Healthcare | 192,000.0 | $21.2M | 0.86% | NEW | — | $110.66 | +5.5% |
| 5 | CNTX | CONTEXT THERAPEUTICS INC | Healthcare | 6,963,141.0 | $18.2M | 0.74% | NEW | — | $2.62 | -0.8% |
| 6 | VIR | VIR BIOTECHNOLOGY INC | Healthcare | 2,002,000.0 | $17.9M | 0.73% | NEW | — | $8.96 | +2.6% |
| 7 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 292,000.0 | $17.0M | 0.69% | NEW | — | $58.15 | -6.8% |
| 8 | TVTX | TRAVERE THERAPEUTICS INC | Healthcare | 546,000.0 | $16.2M | 0.66% | NEW | — | $29.71 | +49.5% |
| 9 | TNDM | TANDEM DIABETES CARE INC | Healthcare | 783,000.0 | $15.0M | 0.61% | NEW | — | $19.17 | -21.9% |
| 10 | CORT | CORCEPT THERAPEUTICS INC | Healthcare | 285,531.0 | $11.5M | 0.47% | NEW | — | $40.31 | +49.4% |
| 11 | SOPH | SOPHIA GENETICS SA | Healthcare | 1,850,000.0 | $9.2M | 0.37% | NEW | — | $4.95 | -1.4% |
| 12 | BDSX | BIODESIX INC | Healthcare | 416,599.0 | $6.0M | 0.24% | NEW | — | $14.50 | +3.0% |
| 13 | RLMD | RELMADA THERAPEUTICS INC | Healthcare | 842,106.0 | $5.9M | 0.24% | NEW | — | $6.96 | +1.1% |
| 14 | CGEM | CULLINAN THERAPEUTICS INC | Healthcare | 410,200.0 | $5.8M | 0.24% | NEW | — | $14.21 | -2.6% |
| 15 | — | IMMUNIC INC | — | 4,500,000.0 | $5.0M | 0.20% | NEW | — | $1.11 | — |
| 16 | LRMR | LARIMAR THERAPEUTICS INC | Healthcare | 1,066,960.0 | $4.8M | 0.19% | NEW | — | $4.50 | -23.3% |
| 17 | — | ETON PHARMACEUTICALS INC | — | 166,381.0 | $4.1M | 0.17% | NEW | — | $24.68 | — |
| 18 | — | SAB BIOTHERAPEUTICS INC | — | 1,050,000.0 | $4.0M | 0.16% | NEW | — | $3.83 | — |
| 19 | PRCT | PROCEPT BIOROBOTICS CORP | Healthcare | 160,000.0 | $4.0M | 0.16% | NEW | — | $25.01 | +16.0% |
| 20 | TECX | TECTONIC THERAPEUTIC INC | Healthcare | 121,684.0 | $3.8M | 0.15% | NEW | — | $30.91 | -5.8% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%